The medical industry is begging to be disrupted

Spotting the bottlenecks is the answer

Illustration of the morphology of coronaviruses
Illustration of the morphology of coronaviruses
Illustration of the morphology of coronaviruses, source Wikipedia

It’s not the development, it’s the testing

What is actually slowing the final product down is the testing part and the regulations that dictates it.

High risk, high reward, low competition

I am currently thinking a lot about risk and competition. I’d argue that high risk businesses result in high barrier to entry, hence low competition and low innovation. Honestly, I need to find literature to validate this point of view. But for now, this sound obvious to me. And thus, I feel what is holding the innovation in medicine back in the high risk imposed by the slow testing process. If you have to test a medicine for a year before getting it approved, this means you are also uncertain whether there will still be a need for that medicine in a year or not. As a result, the companies working on vaccinations are limited.

Written by

Machine Learning engineer, Data Visualisation book author, and a bunch of other things, http://www.tarekamr.com/

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store